Home › Research › Brain scans and imaging
Atrophy of the corpus callosum in Alzheimer's disease versus healthy aging
Janowsky JS, Kaye JA, Carper RA.. Journal of the American Geriatrics Society, 1996-07-01
Topic: Amyloid, tau and blood-test diagnosis
Plain-language summary
Objective To investigate the specificity of atrophic changes in the corpus callosum (CC) compared with the cerebellum and pons in patients with Alzheimer Disease (AD), healthy elderly subjects (HE), and a sample of prospectively studied subjects who have developed cognitive decline or "incipient dementia" (ID). Design Cross-sectional comparison by age using quantitative MRI. Setting Ambulatory research unit. Participants Sixty HE subjects (mean age 78.2 years; range 66-95), 20 ID subjects (mean age 88.1 years; range 78-98) and 39 AD subjects (mean age 72.2 years; range 52-91) were enrolled in longitudinal studies of healthy aging or AD. The population was selected for optimal health; all were examined to exclude medical, neurological and psychiatric illness. Measurements Brain atrophy by quantitative MRI. Results AD subjects had smaller CC than HE or ID subjects, who did not differ from each other. All three sectors of the CC were smaller in AD than in HE or ID subjects. The cross sectional area of the cerebellum and pons did not differ between groups. HE and ID subjects showed a significant decline in CC size with age. No age-related decline was found for AD subjects. The regional atrophy of the CC in AD subjects was significantly related to cognitive function but not to disease duration. Conclusions Atrophy of the CC differentiates HE and ID from AD subjects and tracks the cognitive decline of this disease. In addition, optimally healthy subjects show an age-related decline in callosum size. The atrophy is specific to the CC, a cortical projection system, and does not occur in cerebellum or pons.
What this study adds
Evidence grade: Moderate
This is a cross-sectional study. This cross-sectional MRI study found that people with Alzheimer's disease had smaller corpus callosum size than healthy elderly or incipient dementia subjects, while the cerebellum and pons did not differ between groups. It describes a structural brain difference that may help distinguish Alzheimer's disease, but it does not test a treatment, cure, or prevention.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Janowsky, J. S., Kaye, J. A., & Carper, R. A. (1996). Atrophy of the corpus callosum in Alzheimer's disease versus healthy aging. Journal of the American Geriatrics Society. https://doi.org/10.1111/j.1532-5415.1996.tb03736.x
Vancouver
Janowsky JS, Kaye JA, Carper RA. Atrophy of the corpus callosum in Alzheimer's disease versus healthy aging. Journal of the American Geriatrics Society. 1996. doi:10.1111/j.1532-5415.1996.tb03736.x. PMID: 8675927.
BibTeX
@article{janowsky1996-8675927,
author = {Janowsky, J. S. and Kaye, J. A. and Carper, R. A.},
title = {{Atrophy of the corpus callosum in Alzheimer's disease versus healthy aging}},
journal = {Journal of the American Geriatrics Society},
year = {1996},
doi = {10.1111/j.1532-5415.1996.tb03736.x},
pmid = {8675927},
url = {https://doi.org/10.1111/j.1532-5415.1996.tb03736.x}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.
Key findings
- Objective To investigate the specificity of atrophic changes in the corpus callosum (CC) compared with the cerebellum and pons in patients with Alzheimer Disease (AD), healthy elderly subjects (HE), and a sample of prospectively studied subjects who have developed cognitive decline or "incipient dementia" (ID).
- Results AD subjects had smaller CC than HE or ID subjects, who did not differ from each other.
- HE and ID subjects showed a significant decline in CC size with age.
- The regional atrophy of the CC in AD subjects was significantly related to cognitive function but not to disease duration.
Why it matters
This cross-sectional MRI study found that people with Alzheimer's disease had smaller corpus callosum size than healthy elderly or incipient dementia subjects, while the cerebellum and pons did not differ between groups. It describes a structural brain difference that may help distinguish Alzheimer's disease, but it does not test a treatment, cure, or prevention.
New to this subject? Start with our plain-English guide: Brain scans & tests →
Study details
- Study designcross-sectional
- Evidence strengthModerate
How this study scored 45/100
Published in a peer-reviewed journal, and it is a snapshot of people at one point in time. Scored zero for sample size, effect reported, studied in people and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Journal of the American Geriatrics Society) |
| Journal's citation record | 3 / 4 | Journal of the American Geriatrics Society: journal h-index 344 (OpenAlex, 2026-10-29) |
| Study design | 4 / 12 | A snapshot of people at one point in time |
| Strength of evidence | 3 / 5 | Rated “moderate” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 1 / 5 | 1996 — older than 20 years, still counted |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 5 / 7 | Cited 105 times (OpenAlex, 2026-10-10) |
| Citations per year | 2 / 5 | 3.3 citations a year over 32 year(s) since 1996 |
| Impact for its field and year | 3 / 6 | Cited 4.1× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 1 / 6 | Cited by 2 other studies in this library |
| Still being cited | 0 / 4 | Cited 1 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 2 / 4 | Last-listed author Ruth A. Carper: h-index 24 (OpenAlex, whole career) |
| Institution's track record | 1 / 3 | Oregon Health & Science University: institution h-index 1,025 (OpenAlex) |
| Multicenter collaboration | 1 / 3 | OpenAlex lists 2 institution(s) in 1 country |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 8675927) |
| Free to read | 0 / 2 | Behind a paywall — scores zero |
| Total | 45 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
May need a subscription OpenAlex found no free copy of the full text (checked 6 Feb 1020), so the publisher may charge for it. The PubMed abstract is free.
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here.
Later studies that cite this one
2 studies in the alzhub library list this one in their references.
Related studies in Brain scans and imaging from nearby years
Also tagged “machine”
834 studies in the library carry the topic tag “machine”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 834 tagged studies.